Loading company…
Greenwich, US-based developer of gene therapies for cardiovascular diseases, acquired by Rocket Pharmaceuticals in 2022.
Renovacor, Inc. was founded in 2013 and is headquartered in Greenwich, US. It develops gene therapies aimed at cardiovascular diseases. Rocket Pharmaceuticals, Inc. acquired the company for USD 53 mn in stock on September 21, 2022, and Maggie Cook is CEO. The company has raised USD 11.05 mn through earlier funding rounds.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in